Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective single-arm study of endoscopic resection (ER) following concurrent
chemoradiotherapy for stage I esophageal squamous cell carcinoma, to find if the treatment
combination is useful by assessing its safety and efficacy.